Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review

  • ID: 1648587
  • SWOT Analysis
  • Region: Global
  • 59 pages
  • GlobalData
  • Charles River
1 of 5

FEATURED COMPANIES

  • Almac Group Ltd
  • BioReliance Corp
  • Corgenix Medical Corp
  • Covance Inc
  • Harlan Laboratories Inc
  • Medidata Solutions Inc
  • MORE
Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through its network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

Mar 08, 2018: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure
Feb 21, 2018: Charles River Laboratories Announces New Tumor Model Compendium
Feb 13, 2018: Charles River Laboratories Announces Fourth-Quarter 2017 Financial Results
Feb 13, 2018: Charles River Laboratories Announces Executive Management Appointments
Feb 06, 2018: HemaCare and Charles River Laboratories Announce Strategic Partnership to Accelerate Drug Discovery and Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Almac Group Ltd
  • BioReliance Corp
  • Corgenix Medical Corp
  • Covance Inc
  • Harlan Laboratories Inc
  • Medidata Solutions Inc
  • MORE
Section 1 - About the Company
  • Charles River Laboratories International Inc - Key Facts
  • Charles River Laboratories International Inc - Key Employees
  • Charles River Laboratories International Inc - Key Employee Biographies
  • Charles River Laboratories International Inc - Major Products and Services
  • Charles River Laboratories International Inc - History
  • Charles River Laboratories International Inc - Company Statement
  • Charles River Laboratories International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Charles River Laboratories International Inc - Business Description
  • Business Segment: Discovery and Safety Assessment
  • Overview
  • Performance
  • Business Segment: Manufacturing Support
  • Overview
  • Performance
  • Business Segment: Research Models and Services
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Target Markets
  • Performance
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: US
  • Performance
  • Charles River Laboratories International Inc - Corporate Strategy
  • Charles River Laboratories International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Charles River Laboratories International Inc - Strengths
  • Charles River Laboratories International Inc - Weaknesses
  • Charles River Laboratories International Inc - Opportunities
  • Charles River Laboratories International Inc - Threats
  • Charles River Laboratories International Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Charles River Laboratories International Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 08, 2018: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure
  • Feb 21, 2018: Charles River Laboratories Announces New Tumor Model Compendium
  • Feb 13, 2018: Charles River Laboratories Announces Executive Management Appointments
  • Feb 06, 2018: HemaCare and Charles River Laboratories Announce Strategic Partnership to Accelerate Drug Discovery and Development
  • Feb 01, 2018: Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure
  • Jan 16, 2018: Charles River Laboratories Adds Jean-Paul Mangeolle to Board of Directors
  • Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering
  • Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations
  • Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017
  • Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Charles River Laboratories International Inc, Key Facts
  • Charles River Laboratories International Inc, Key Employees
  • Charles River Laboratories International Inc, Key Employee Biographies
  • Charles River Laboratories International Inc, Major Products and Services
  • Charles River Laboratories International Inc, History
  • Charles River Laboratories International Inc, Subsidiaries
  • Charles River Laboratories International Inc, Key Competitors
  • Charles River Laboratories International Inc, Ratios based on current share price
  • Charles River Laboratories International Inc, Annual Ratios
  • Charles River Laboratories International Inc, Annual Ratios
  • Charles River Laboratories International Inc, Annual Ratios
  • Charles River Laboratories International Inc, Interim Ratios
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Charles River Laboratories International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Charles River Laboratories International Inc, Performance Chart (2013 - 2017)
  • Charles River Laboratories International Inc, Ratio Charts
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • The Jackson Laboratory
  • Redpoint Bio Corp
  • Pharmaceutical Product Development LLC
  • MLM Medical Labs GmbH
  • Medidata Solutions Inc
  • IMR Partner International GmbH
  • Harlan Laboratories Inc
  • Covance Inc
  • Corgenix Medical Corp
  • BioReliance Corp
  • Almac Group Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll